Selected Grants
REDEFINE NN9838-4942
Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2023 - 2027Molecular Transducers of Physical Activity and Health: NC Consortium Clinical Site
ResearchCo Investigator · Awarded by National Institute of Arthritis and Musculoskeletal and Skin Diseases · 2016 - 2026Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) - Microbiome Collection
Clinical TrialCo Investigator · Awarded by The George Washington University · 2012 - 2026Semaglutide effects on cardiovascular outcomes in people with overweight or obesity
Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2019 - 2024External Relationships
- Gilead Sciences, Inc.
- Novo Nordisk
- Regeneron Pharmaceuticals
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.